Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page
- Check4 days agoChange Detected- Italy location entry updated from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131.SummaryDifference0.0%

- Check12 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdministrative changes: addition of revision v3.4.2 and removal of prior notices (including the lapse funding notice and revision v3.4.1); these updates do not affect study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status has been added, including a link to cc.nih.gov and opm.gov. Revision metadata now shows Revision: v3.4.1 with dates 2026-02-03, 2026-01-30, and 2026-01, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedShow glossary toggle added to provide definitions for terms used in the study details. The page now displays updated metadata labels, including a new Revision: v3.4.0 and Last Update Posted, with minor formatting adjustments to related fields such as No FEAR Act Data.SummaryDifference0.2%

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.